ArticleVaccines2026

Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds.

Julia Glanternik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.